YUKI YAMAMOTO

Last Updated :2025/05/09

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Pharmaceutical Sciences), Assistant Professor (Special Appointment)
E-mail
yyamamotohiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2019/04, 2020/03, Japan Society for the Promotion of Science, Research Fellowship for Young Scientists, DC2

Academic Degrees

  • Hiroshima University
  • Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Pharmacy;Biological pharmacy

Affiliated Academic Societies

Educational Activity

Course in Charge

  1. 2025, Undergraduate Education, 3Term, Biochemistry V
  2. 2025, Undergraduate Education, Intensive, Biochemistry V
  3. 2025, Undergraduate Education, 4Term, Biochemistry VI
  4. 2025, Undergraduate Education, Intensive, Biochemistry VI
  5. 2025, Undergraduate Education, 4Term, Cell Biology
  6. 2025, Undergraduate Education, Second Semester, Experiments of Cellular and Molecular Biology
  7. 2025, Graduate Education (Doctoral Program) , Second Semester, Advanced Research in Pharmaceutical Science

Research Activities

Academic Papers

  1. Assessment of the expression of microRNAs-221-3p,-146a-5p,-16-5p and BCL2 in oncocytic carcinoma of the breast: A case report, ONCOLOGY LETTERS, 26(6), 202312
  2. Immunocyte Derived Exosomes: Insight into the Potential Chemo- immunotherapeutic Nanocarrier Targeting the Tumor Microenvironment, ACS BIOMATERIALS SCIENCE & ENGINEERING, 9(1), 20-39, 20230109
  3. Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence, JOURNAL OF CLINICAL MEDICINE, 11(24), 202212
  4. Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer, CANCER SCIENCE, 111(5), 1856-1861, 202005
  5. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles, CANCER SCIENCE, 111(6), 2104-2115, 202006

Invited Lecture, Oral Presentation, Poster Presentation

  1. Preclinical evaluation of a novel senescence-associated miRNA miR-3140-3p for malignant pleural mesothelioma, Yuki Yamamoto, Ayaka Nishiura, Kimiyoshi Yano, Noriaki Matsuda, Ryou-u Takahashi, Yasuhiro Tsutani, Morihito Okada, Hidetoshi Tahara, AACR Virtual Annual Meeting 2020, 2020/06/22, Without Invitation, English, Online
  2. A treatment of malignant pleural mesothelioma using a novel senescence-associated miRNA miR-3140-3p, Yuki Yamamoto, Kimiyoshi Yano, Noriaki Matsuda, Ryou-u Takahashi, Morihito Okada, Hidetoshi Tahara, The 79th Annual Meeting of the Japanese Cancer Association, 2020/10/01, Without Invitation, Japanese, Hiroshima

Social Activities

History as Peer Reviews of Academic Papers

  1. 2023, Cancer Science, Others, 2
  2. 2020, Cancer Science, Others, 1